Bioventix 

€17.90
93
+€0.20+1.13% Thursday 15:46

Statistics

Day High
18.3
Day Low
17.7
52W High
35.6
52W Low
17.7
Volume
0
Avg. Volume
2
Mkt Cap
0
P/E Ratio
12.29
Dividend Yield
9.58%
Dividend
1.71

Upcoming

Dividends

9.58%Dividend Yield
Apr 26
€0.80
Nov 25
€0.91
Apr 25
€0.81
Nov 24
€1.05
Apr 24
€0.80
10Y Growth
13.24%
5Y Growth
6.9%
3Y Growth
-0.44%
1Y Growth
-0.23%

Earnings

30MarExpected
Q4 2025
0.81
1.14
1.47
1.81
Expected EPS
N/A
Actual EPS
0.80509039112

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 51B.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap166.17B
Abbott Laboratories offers diagnostic solutions and competes in the antibody space, overlapping with Bioventix's antibody development for diagnostics.
Danaher
DHR
Mkt Cap140.09B
Danaher Corporation, through its subsidiaries, provides professional, medical, industrial, and commercial products and services, including diagnostic solutions that compete with Bioventix.
Resmed
RMD
Mkt Cap30.41B
ResMed Inc. specializes in medical devices for respiratory disorders but also ventures into health diagnostics, indirectly competing with Bioventix's diagnostic technologies.
Bio-Rad Laboratories
BIO
Mkt Cap7.94B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, directly competing with Bioventix in the diagnostics sector.
Thermo Fisher Scientific
TMO
Mkt Cap194.52B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Bioventix in the diagnostics and research market.
Qiagen NV
QGEN
Mkt Cap8.07B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics market alongside Bioventix.
Bruker
BRKR
Mkt Cap9.38B
Bruker Corporation designs, manufactures, and distributes scientific instruments and analytical and diagnostic solutions, competing with Bioventix in the diagnostics and analytical solutions sector.
Waters
WAT
Mkt Cap37.24B
Waters Corporation produces analytical instruments, software, and services for the healthcare sector, including diagnostics, competing with Bioventix in the development of diagnostic solutions.
Agilent Technologies
A
Mkt Cap36.91B
Agilent Technologies, Inc. provides application-focused solutions in the life sciences, diagnostics, and applied chemical markets, competing with Bioventix in the diagnostics and research fields.

About

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Show more...
CEO
Country
United Kingdom
ISIN
GB00B4QVDF07

Listings

0 Comments

Share your thoughts

FAQ

What is Bioventix stock price today?
The current price of 51B.STU is €17.90 EUR — it has increased by +1.13% in the past 24 hours. Watch Bioventix stock price performance more closely on the chart.
What is Bioventix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Bioventix stocks are traded under the ticker 51B.STU.
Is Bioventix stock price growing?
51B.STU stock has risen by +0% compared to the previous week, the month change is a +3.47% rise, over the last year Bioventix has showed a -41.5% decrease.
When is the next Bioventix earnings date?
Bioventix is going to release the next earnings report on October 26, 2026.
What were Bioventix earnings last quarter?
51B.STU earnings for the last quarter are 0.81 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Bioventix pay dividends?
Yes, 51B.STU dividends are paid semi-annual. The last dividend per share was 0.8 EUR. As of today, Dividend Yield (FWD)% is 9.58%.
In which sector is Bioventix located?
Bioventix operates in the Other sector.
When did Bioventix complete a stock split?
Bioventix has not had any recent stock splits.